Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 650

1.

Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

Int Clin Psychopharmacol. 2001 Nov;16(6):325-30.

PMID:
11712620
2.
3.

An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.

Tamrakar SM, Nepal MK, Koirala NR, Sharma VD, Gurung CK, Adhikari SR.

Kathmandu Univ Med J (KUMJ). 2006 Apr-Jun;4(2):152-60.

PMID:
18603890
4.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
6.

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study.

Claus A, Bollen J, De Cuyper H, Eneman M, Malfroid M, Peuskens J, Heylen S.

Acta Psychiatr Scand. 1992 Apr;85(4):295-305.

PMID:
1375801
7.

Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients.

Blin O, Azorin JM, Bouhours P.

J Clin Psychopharmacol. 1996 Feb;16(1):38-44.

PMID:
8834417
8.
9.

A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder.

Janicak PG, Keck PE Jr, Davis JM, Kasckow JW, Tugrul K, Dowd SM, Strong J, Sharma RP, Strakowski SM.

J Clin Psychopharmacol. 2001 Aug;21(4):360-8.

PMID:
11476119
10.

The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

Marder SR, Davis JM, Chouinard G.

J Clin Psychiatry. 1997 Dec;58(12):538-46. Erratum in: J Clin Psychiatry 1998 Apr;59(4):200.

PMID:
9448657
11.

Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

Psychopharmacology (Berl). 2005 Feb;178(1):35-40. Epub 2004 Jul 31.

PMID:
15289996
12.

Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.

Zhong KX, Sweitzer DE, Hamer RM, Lieberman JA.

J Clin Psychiatry. 2006 Jul;67(7):1093-103.

PMID:
16889453
13.

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.

Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.

J Clin Psychopharmacol. 1993 Feb;13(1):25-40. Erratum in: J Clin Psychopharmacol 1993 Apr;13(2):149.

PMID:
7683702
14.

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia.

J Clin Psychiatry. 2007 Nov;68(11):1763-74.

PMID:
18052570
15.

Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia.

Lindström E, Eriksson B, Hellgren A, von Knorring L, Eberhard G.

Clin Ther. 1995 May-Jun;17(3):402-12.

PMID:
7585844
16.

[Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].

López Ibor JJ, Ayuso JL, Gutiérrez M, Guimon J, Herraiz ML, Chinchilla A, Ayuso JL Jr, González Pinto A, Eguiluz I, Fernández A.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1996 Jul-Aug;24(4):165-72. Spanish.

PMID:
8984849
17.

Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety.

Davies A, Adena MA, Keks NA, Catts SV, Lambert T, Schweitzer I.

Clin Ther. 1998 Jan-Feb;20(1):58-71.

PMID:
9522104
18.

Risperidone in the treatment of schizophrenia: results of a study of patients from Germany, Austria, and Switzerland.

Möller HJ, Bäuml J, Ferrero F, Fuger J, Geretsegger C, Kasper S, Kissling W, Schubert H.

Eur Arch Psychiatry Clin Neurosci. 1997;247(6):291-6.

PMID:
9477007
19.

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.

Freeman HL.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. Review.

PMID:
9218163
20.

A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia.

Zhang XY, Zhou DF, Zhang PY, Wu GY, Su JM, Cao LY.

J Clin Psychiatry. 2001 Nov;62(11):878-83.

PMID:
11775047

Supplemental Content

Support Center